Macedonian Drug Maker Alkaloid's 9-Mo Prelim Net Profit Rises 5.2% Y/Y - Table

Alkaloid’s sales revenue increased to 3.12 billion denars in the January-September period from 2.67 billion a year earlier.

Following are figures from Alkaloid's income statement sent to the Macedonian Stock Exchange (MSE), where the company is listed (in millions of denars):

Alkaloid's shares are among the 10 most liquid stocks in the blue-chip index of the Macedonian Stock Exchange. They were quoted at 4,518 denars on Tuesday, 3% up from a day earlier.

Alkaloid says it is the market leader in Macedonia with a market share of 20 to 25 percent. Based in the capital, Skopje, Alkaloid (www.alkaloid.com.mk) has representative offices in over 10 countries and distributes its products in some 30 countries.

(1 euro = 62.2332 denars)